Stock Screener App

Gratuito -

Installare

23.81

0.00% 0.00

Iambic Therapeutics, Inc. Common Stock (IAM)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Iambic Therapeutics, Inc. Common Stock Borsa (IAM) Ultime notizie

Iambic Therapeutics CFO Michael Secora Granted RSUs and Stock Options on October 14, 2026 - Kalkine Media

Form 4 Iambic Therapeutics: Michael Secora (CFO & Chief Corp Dev Ofcr) For: 14 October - Investing.com India

Wilson Sonsini Advises Iambic Therapeutics on $150 Million Initial Public Offering - Wilson Sonsini

Total common shares outstanding of Iambic Therapeutics, Inc. – BOATS:IAM - TradingView

IAM SEC FilingsIambic Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia

Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance

Rachlin Evan Lockwood Reports Initial Indirect Ownership in Iambic Therapeutics via Ascenta Capital - Kalkine Media

Iambic Therapeutics prices IPO at $16 per share to raise $150 million - scanx.trade

Iambic Therapeutics prices IPO at $16 per share - Investing.com

Articles from Iambic Therapeutics, Inc. - FinancialContent

Iambic Announces Pricing of Initial Public Offering - Business Wire

Iambic Therapeutics, Inc. has completed an IPO in the amount of $150 million. - www.marketscreener.com

Iambic Therapeutics Files to List Common Stock on Nasdaq Exchange - Kalkine Media

Diluted net income available to common stockholders of IAMBIC THERAPEUTICS INC – NASDAQ:IAM - TradingView

IAMBIC THERAPEUTICS INC Statistics – NASDAQ:IAM - TradingView

NVIDIA-Backed Iambic Therapeutics Files for IPO - Digital Health News

Iambic Therapeutics, Inc. has filed an IPO in the amount of $100 million. - www.marketscreener.com

DRTS

$12.29

6.61%

DMRA

$18.44

1.60%

BCAX

$16.78

4.77%

SNDX

$12.90

5.49%

NBTX

$21.30

4.18%

OMER

$16.20

13.78%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters